OLIPASS (244460) | AccidentalOrder

KOSDAQ · 1,651 KRW · As of Aug 26, 2026 close

Mkt Cap

13.4B

Rev (2022)

2.3B

Op Inc (2022)

-24.1B

Net Inc (2022)

-24.8B

PBR

7.89

52W

1K~1K

OLIPASS operates in the Pharmaceuticals sector.

Legal name: OLIPASS CORPORATION

In fiscal year 2022, OLIPASS (244460) reported revenue of 2.3 billion KRW, up 169.6% from 852 million KRW a year earlier.

Operating profit was -24.1 billion KRW and net income was -24.8 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 13.4 billion KRW, with a P/B of 7.89.

These figures can be verified in the DART filing (receipt no. 20260320001227).

Year	Rev	Op Inc	Net Inc
2022	2.3B	-24.1B	-24.8B
2021	852M	-25.1B	-25.7B
2020	2.9B	-23.7B	-24.6B

5 applicable out of 8 items

기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)

Semi-Annual Report (2026.06)

Large Shareholding Report (Simplified)

Checks

5 of 8 checked items currently applicable.

Market Cap & Price: Market cap is below the delisting threshold for 398 consecutive days.

Administrative Designation: 4 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Disclaimer of opinion. [source]

Convertible Bonds: Convertible bonds outstanding with 0.6% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 7 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)
2026-08-14	Semi-Annual Report (2026.06)
2026-07-31	Large Shareholding Report (Simplified)